Stella P Kim
Overview
Explore the profile of Stella P Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
953
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bergman R, Stefanovski D, Kim S
Curr Opin Biotechnol
. 2014 Jul;
28:165-70.
PMID: 24976265
Prevalence of Type 2 diabetes has increased at an alarming rate, highlighting the need to correctly predict the development of this disease in order to allow intervention and thus, slow...
12.
Ader M, Stefanovski D, Richey J, Kim S, Kolka C, Ionut V, et al.
Diabetes
. 2013 Dec;
63(6):1914-9.
PMID: 24353184
Accurate quantification of insulin resistance is essential for determining efficacy of treatments to reduce diabetes risk. Gold-standard methods to assess resistance are available (e.g., hyperinsulinemic clamp or minimal model), but...
13.
Ader M, Stefanovski D, Kim S, Richey J, Ionut V, Catalano K, et al.
Obesity (Silver Spring)
. 2013 Oct;
22(5):1238-45.
PMID: 24123967
Objective: Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other...
14.
Kim S
Adipocyte
. 2013 May;
2(1):47-49.
PMID: 23700552
Visceral fat has long been associated with the development of insulin resistance. Although the mechanism is not well understood, it has been suggested that an increase in this fat depot...
15.
Kim S, Woolcott O, Hsu I, Stefanoski D, Harrison L, Zheng D, et al.
Am J Physiol Endocrinol Metab
. 2012 Mar;
302(10):E1261-8.
PMID: 22374758
The endocannabinoid system is highly implicated in the development of insulin resistance associated with obesity. It has been shown that antagonism of the CB(1) receptor improves insulin sensitivity (S(I)). However,...
16.
Kabir M, Stefanovski D, Hsu I, Iyer M, Woolcott O, Zheng D, et al.
Obesity (Silver Spring)
. 2011 Aug;
19(11):2121-9.
PMID: 21836643
Adipocyte size plays a key role in the development of insulin resistance. We examined longitudinal changes in adipocyte size and distribution in visceral (VIS) and subcutaneous (SQ) fat during obesity-induced...
17.
Woolcott O, Bergman R, Richey J, Kirkman E, Harrison L, Ionut V, et al.
Pancreas
. 2011 Jul;
41(1):31-8.
PMID: 21792087
Objectives: The canine model has been used extensively to improve the human pancreatic islet isolation technique. At the functional level, dog islets show high similarity to human islets and thus...
18.
Stefanovski D, Richey J, Woolcott O, Lottati M, Zheng D, Harrison L, et al.
PLoS One
. 2011 Apr;
6(3):e18134.
PMID: 21479217
Objective: Insulin resistance induces hyperinsulinemic compensation, which in turn maintains almost a constant disposition index. However, the signal that gives rise to the hyperinsulinemic compensation for insulin resistance remains unknown....
19.
Richey J, Woolcott O, Stefanovski D, Harrison L, Zheng D, Lottati M, et al.
Am J Physiol Endocrinol Metab
. 2009 Apr;
296(6):E1311-8.
PMID: 19366874
We investigated whether rimonabant, a type 1 cannabinoid receptor antagonist, reduces visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) in dogs maintained on a hypercaloric high-fat diet (HHFD). To...
20.
Hsu I, Kim S, Kabir M, Bergman R
Am J Clin Nutr
. 2008 Feb;
86(3):s867-71.
PMID: 18265480
The term metabolic syndrome describes the association between obesity, insulin resistance, and the risk of several prominent chronic diseases, including cancer. The causal link between many of these components remains...